{"id":"j022x-st","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL392303","moleculeType":"Small molecule","molecularWeight":"479.54"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a small molecule kinase inhibitor developed by Pierre Fabre, J022X ST is designed to inhibit one or more receptor tyrosine kinases implicated in oncogenic signaling. The drug is currently in phase 3 clinical development, indicating it has demonstrated sufficient preclinical and early clinical activity to warrant late-stage testing in patient populations.","oneSentence":"J022X ST is a tyrosine kinase inhibitor that targets specific molecular pathways involved in cancer cell proliferation and survival.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:17:32.963Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT01948856","phase":"PHASE3","title":"CLEARI (Clinical Efficacy Assessment on Recurrent Upper-Respiratory Tract Infections) Study","status":"COMPLETED","sponsor":"Pierre Fabre Medicament","startDate":"2013-09","conditions":"Recurrent Upper-Respiratory Tract Infections","enrollment":1003}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":151633,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"J022X ST","genericName":"J022X ST","companyName":"Pierre Fabre Medicament","companyId":"pierre-fabre-medicament","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}